Hoboken, N.J., February 4, 2008 Deborah E. Wiley, Chairman of The Wiley Foundation, and Senior Vice President, John Wiley & Sons, Inc., announced today that the seventh annual Wiley Prize in Biomedical Sciences will be awarded to Dr. Richard P. Lifton of the Yale University School of Medicine.
Dr. Lifton, Chairman of the Department of Genetics, and Sterling Professor of Genetics and Internal Medicine, at the Yale University School of Medicine, and Investigator of the Howard Hughes Medical Institute, was chosen for his discovery of the genes that cause many forms of high and low blood pressure in humans.
The Wiley Prize in Biomedical Sciences recognizes contributions that have opened new fields of research or have advanced novel concepts or their applications in a particular biomedical discipline. It honors a specific contribution or a series of contributions that demonstrate significant leadership and innovation. The award will be presented to Dr. Lifton on April 4, 2008, at The Rockefeller University, in New York City. Dr. Lifton, who has also been invited to present a public lecture that day at The Rockefeller University, will receive a $35,000 grant from the Wiley Foundation.
The Wiley Prize is being awarded to Dr. Lifton for identifying multiple genes in humans that are linked to high and low blood pressure, said Dr. Gnter Blobel, Chairman of the awards jury for the Wiley Prize. All of the genes identified are involved in the regulation of salt balance by the kidney. Dr. Liftons findings highlight the importance of dietary salt in the causation of hypertension, a major risk factor in cardiovascular disease, the leading cause of death worldwide, he continued.
Dr. Blobel, a John D. Rockefeller, Jr. Professor of Cell Biology at The Rockefeller University, was awarded the Nobel Prize for Physiology or Medicine in 1999. The Wiley Prize awards jury also includes Dr. Qais Al-Awqati, a physiologist at Columbia University's
|Contact: Susan Spilka|